Herbal Medicine
Routledge (Verlag)
978-0-7890-1620-1 (ISBN)
framing the limitations of the current situation with brief examples
reviewing the regulatory history of herbal medicines in the United States
placing the situation in an international context by also examining regulations in Canada, Germany, France, and the United Kingdom
illustrating the practical implications of U.S. regulations with six examples that demonstrate how herbal medicines could contribute more to consumer health--and the public health risks associated with the current regulatory situation
analyzing the public health issues related to safety, research, clinical practice, consumer interests, business, media, and federal government
offering key, high-impact recommendations for future policyConsumers, health care professionals, business people in the domestic and foreign herb industries, researchers, health plan executives, food and drug attorneys and policymakers, as well as educators and students, will all find this book essential to their understanding of the workings of the herbal medicine industry. Visit the author’s website at http://www.herbalchaos.com
Tyler, Virginia M; Richter, Rowena
Foreword
Preface
Acknowledgments
Part I: Introduction
Chapter 1. Overview
The Dilemma
Purpose of This Book
Part II. Review of Regulations
Chapter 2. United States
History of Regulation of Botanicals
Current Legal Classification of Botanicals
Current Regulation and Surveillance of Botanicals
Chapter 3. Canada
Legal Classification
Proof of Safety and Efficacy
Manufacturing Standards
Labeling, Advertising, Distribution, and Retail Sale
Postmarket Safety and Surveillance
Chapter 4. Germany
Legal Classification
Proof of Safety and Efficacy
Manufacturing Standards
Labeling, Advertising, Distribution, and Retail Sale
Postmarket Safety and Surveillance
Chapter 5. France
Legal Classification
Proof of Safety and Efficacy
Manufacturing Standards
Labeling, Advertising, Distribution, and Retail Sale
Postmarket Safety and Surveillance
Chapter 6. United Kingdom
Legal Classification
Proof of Safety and Efficacy
Manufacturing Standards
Labeling, Advertising, Distribution, and Retail Sale
Postmarket Safety and Surveillance
Chapter 7. Summary of International Regulatory Review
Part III. Illustrative Examples
Chapter 8. Examples with Potential Public Health Benefits
St. John’s Wort and Moderate Depression
Ginkgo and Alzheimer’s Disease
Echinacea and the Common Cold
Chapter 9. Examples That Present Public Health Risks
Ephedra
Adulteration Case Report
Comfrey
Part IV. Analysis of Current and Potential Impact on Public Health
Chapter 10. Safety
Absence of Premarket Approval
Postmarket Surveillance
Chapter 11. Research
Patent Protection
Product-Specific Research by Manufacturers
Government Research Funding
Epidemiological Research
Chapter 12. Clinical Practice, Managed Care, and Health Insurance
Education of Medical Professionals
Coordination of Treatment
Access to Botanical Treatment
Opportunities for Cost Savings
Chapter 13. Consumer Interests
Consumers As a Political Force
Sorting Through the Morass
Chapter 14. The Role of Business, Media, and the Government
The Role of Business and Marketing
The Role of Media
The Role of the Federal Government
Part V. Conclusion
Chapter 15. Summary and Recommendations
Summary of Findings
Recommendations
Appendix A. U.S. Dietary Supplement Health and Education Act of 1994
Appendix B. Recommendations of the Canadian Standing Committee on Health
Appendix C. Abbreviations and Acronyms
Notes
Index
Erscheint lt. Verlag | 7.11.2002 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 156 x 216 mm |
Gewicht | 440 g |
Themenwelt | Medizin / Pharmazie ► Naturheilkunde |
Medizin / Pharmazie ► Pharmazie | |
Technik | |
ISBN-10 | 0-7890-1620-6 / 0789016206 |
ISBN-13 | 978-0-7890-1620-1 / 9780789016201 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich